{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:32:38Z","timestamp":1707525158325},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,1]]},"DOI":"10.7759\/cureus.42816","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T20:53:00Z","timestamp":1690923180000},"source":"Crossref","is-referenced-by-count":0,"title":["A Rare Case of Hansen\u2019s Disease Complicated by G6PD Deficiency"],"prefix":"10.7759","author":[{"given":"Payton","family":"Yerke Hansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisha","family":"Myers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karan","family":"Rajalingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Labanowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.13301","article-title":"Leprosy - an overview of clinical features, diagnosis, and treatment","volume":"15","author":"Fischer M","year":"2017","unstructured":"Fischer M. Leprosy - an overview of clinical features, diagnosis, and treatment. J Dtsch Dermatol Ges. 2017, 15:801-27. 10.1111\/ddg.13301","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20142450","article-title":"Leprosy: review of the epidemiological, clinical, and etiopathogenic aspects - part 1","volume":"89","author":"Last\u00f3ria JC","year":"2014","unstructured":"Last\u00f3ria JC, Abreu MA. Leprosy: review of the epidemiological, clinical, and etiopathogenic aspects - part 1. An Bras Dermatol. 2014, 89:205-18. 10.1590\/abd1806-4841.20142450","journal-title":"An Bras Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-222352","article-title":"Coinfection of leprosy and tuberculosis","volume":"2018","author":"Shetty S","year":"2018","unstructured":"Shetty S, Umakanth S, Manandhar B, Nepali PB. Coinfection of leprosy and tuberculosis. BMJ Case Rep. 2018, 2018:10.1136\/bcr-2017-222352","journal-title":"BMJ Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4349-9","article-title":"Development of a combined RLEP\/16S rRNA (RT) qPCR assay for the detection of viable M. leprae from nasal swab samples","volume":"19","author":"Beissner M","year":"2019","unstructured":"Beissner M, Woestemeier A, Saar M, et al.. Development of a combined RLEP\/16S rRNA (RT) qPCR assay for the detection of viable M. leprae from nasal swab samples. BMC Infect Dis. 2019, 19:753. 10.1186\/s12879-019-4349-9","journal-title":"BMC Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7205\/milmed-d-02-9208","article-title":"The diagnostic challenge of Hansen's disease","volume":"174","author":"Chambers JA","year":"2009","unstructured":"Chambers JA, Baffi CW, Nash KT. The diagnostic challenge of Hansen's disease. Mil Med. 2009, 174:652-6. 10.7205\/milmed-d-02-9208","journal-title":"Mil Med"},{"key":"ref6","article-title":"Incidence of Hansen's disease--United States, 1994-2011","volume":"63","author":"Nolen L","year":"2014","unstructured":"Nolen L, Haberling D, Scollard D, Truman R, Rodriguez-Lainz A, Blum L, Blaney D. Incidence of Hansen's disease--United States, 1994-2011. MMWR Morb Mortal Wkly Rep. 2014, 63:969-72.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2019.100899","article-title":"Epidemiological aspects of leprosy","volume":"66","author":"Sarode G","year":"2020","unstructured":"Sarode G, Sarode S, Anand R, Patil S, Jafer M, Baeshen H, Awan KH. Epidemiological aspects of leprosy. Dis Mon. 2020, 66:100899. 10.1016\/j.disamonth.2019.100899","journal-title":"Dis Mon"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.5700","article-title":"Dapsone induced hemolysis in a patient with Hansen's disease and G6PD deficiency: a preventable peril","volume":"10","author":"Ghorui AK","year":"2022","unstructured":"Ghorui AK, Patra PK. Dapsone induced hemolysis in a patient with Hansen's disease and G6PD deficiency: a preventable peril. Clin Case Rep. 2022, 10:e05700. 10.1002\/ccr3.5700","journal-title":"Clin Case Rep"},{"key":"ref9","article-title":"Hemolytic anemia in patients receiving daily dapsone for the treatment of leprosy","volume":"83","author":"Deps P","year":"2012","unstructured":"Deps P, Guerra P, Nasser S, Simon M. Hemolytic anemia in patients receiving daily dapsone for the treatment of leprosy. Lepr Rev. 2012, 83:305-7.","journal-title":"Lepr Rev"},{"key":"ref10","article-title":"Glucose-6-phosphate dehydrogenase (G6PD) deficiency among tribal populations of India - country scenario","volume":"141","author":"Mukherjee MB","year":"2015","unstructured":"Mukherjee MB, Colah RB, Martin S, Ghosh K. Glucose-6-phosphate dehydrogenase (G6PD) deficiency among tribal populations of India - country scenario. Indian J Med Res. 2015, 141:516-20.","journal-title":"Indian J Med Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5935\/0305-7518.20000074","article-title":"Combination of rifapentine-moxifloxacin-minocycline (PMM) for the treatment of leprosy","volume":"71","author":"Ji B","year":"2000","unstructured":"Ji B, Grosset J. Combination of rifapentine-moxifloxacin-minocycline (PMM) for the treatment of leprosy. Lepr Rev. 2000, 71:S81-7. 10.5935\/0305-7518.20000074","journal-title":"Lepr Rev"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.4269\/ajtmh.2004.70.197","article-title":"Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy","volume":"70","author":"Villahermosa LG","year":"2004","unstructured":"Villahermosa LG, Fajardo TT Jr, Abalos RM, et al.. Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy. Am J Trop Med Hyg. 2004, 70:197-200.","journal-title":"Am J Trop Med Hyg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2015.04.001","article-title":"Vitamin D receptor expression levels determine the severity and complexity of disease progression among leprosy reaction patients","volume":"6","author":"Mandal D","year":"2015","unstructured":"Mandal D, Reja AH, Biswas N, Bhattacharyya P, Patra PK, Bhattacharya B. Vitamin D receptor expression levels determine the severity and complexity of disease progression among leprosy reaction patients. New Microbes New Infect. 2015, 6:35-9. 10.1016\/j.nmni.2015.04.001","journal-title":"New Microbes New Infect"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2020.101670","article-title":"Use of methotrexate for leprosy reactions. Experience of a referral center and systematic review of the literature","volume":"37","author":"Perez-Molina JA","year":"2020","unstructured":"Perez-Molina JA, Arce-Garcia O, Chamorro-Tojeiro S, Norman F, Monge-Maillo B, Comeche B, Lopez-Velez R. Use of methotrexate for leprosy reactions. Experience of a referral center and systematic review of the literature. Travel Med Infect Dis. 2020, 37:101670. 10.1016\/j.tmaid.2020.101670","journal-title":"Travel Med Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01162-07","article-title":"Powerful bactericidal activity of moxifloxacin in human leprosy","volume":"52","author":"Pardillo FE","year":"2008","unstructured":"Pardillo FE, Burgos J, Fajardo TT, et al.. Powerful bactericidal activity of moxifloxacin in human leprosy. Antimicrob Agents Chemother. 2008, 52:3113-7. 10.1128\/AAC.01162-07","journal-title":"Antimicrob Agents Chemother"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.5070\/D375Z6499Z","article-title":"Lepromatous leprosy","volume":"13","author":"Booth AV","year":"2007","unstructured":"Booth AV, Kovich OI. Lepromatous leprosy. Dermatol Online J. 2007, 13:9.","journal-title":"Dermatol Online J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.10.138","article-title":"Leprosy: treatment and management of complications","volume":"83","author":"Maymone MB","year":"2020","unstructured":"Maymone MB, Venkatesh S, Laughter M, et al.. Leprosy: treatment and management of complications. J Am Acad Dermatol. 2020, 83:17-30. 10.1016\/j.jaad.2019.10.138","journal-title":"J Am Acad Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/01.JAA.0000586304.65429.a7","article-title":"G6PD deficiency: an update","volume":"32","author":"Harcke SJ","year":"2019","unstructured":"Harcke SJ, Rizzolo D, Harcke HT. G6PD deficiency: an update. JAAPA. 2019, 32:21-6. 10.1097\/01.JAA.0000586304.65429.a7","journal-title":"JAAPA"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2450\/2017.0326-16","article-title":"Red blood cell components: time to revisit the sources of variability","volume":"15","author":"Sparrow RL","year":"2017","unstructured":"Sparrow RL. Red blood cell components: time to revisit the sources of variability. Blood Transfus. 2017, 15:116-25. 10.2450\/2017.0326-16","journal-title":"Blood Transfus"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s12687-017-0330-8","article-title":"A rare disorder or not? How a child with jaundice changed a nationwide regimen in the Netherlands","volume":"8","author":"Heuvel EA","year":"2017","unstructured":"Heuvel EA, Baauw A, Mensink-Dillingh SJ, Bartels M. A rare disorder or not? How a child with jaundice changed a nationwide regimen in the Netherlands. J Community Genet. 2017, 8:335-9. 10.1007\/s12687-017-0330-8","journal-title":"J Community Genet"},{"key":"ref21","article-title":"Caring for glucose-6-phosphate dehydrogenase (G6PD)-deficient patients: implications for pharmacy","volume":"40","author":"Bubp J","year":"2015","unstructured":"Bubp J, Jen M, Matuszewski K. Caring for glucose-6-phosphate dehydrogenase (G6PD)-deficient patients: implications for pharmacy. P T. 2015, 40:572-4.","journal-title":"P T"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028357","article-title":"Performance of the CareStart\u2122 G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening","volume":"6","author":"Kim S","year":"2011","unstructured":"Kim S, Nguon C, Guillard B, et al.. Performance of the CareStart\u2122 G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening. PLoS One. 2011, 6:e28357. 10.1371\/journal.pone.0028357","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2310\/JIM.0b013e31821b8755","article-title":"Vitamin D and the immune system","volume":"59","author":"Aranow C","year":"2011","unstructured":"Aranow C. Vitamin D and the immune system. J Investig Med. 2011, 59:881-6. 10.2310\/JIM.0b013e31821b8755","journal-title":"J Investig Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1177\/20499361221135885","article-title":"Novel approaches in the treatment of Hansen's disease (leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States","volume":"9","author":"Franco-Paredes C","year":"2022","unstructured":"Franco-Paredes C, Garcia-Creighton E, Henao-Mart\u00ednez A, et al.. Novel approaches in the treatment of Hansen's disease (leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States. Ther Adv Infect Dis. 2022, 9:20499361221135885. 10.1177\/20499361221135885","journal-title":"Ther Adv Infect Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ588","article-title":"Quantiferon-Gold tuberculosis test cannot detect latent tuberculosis in patients with leprosy","volume":"61","author":"Rendini T","year":"2015","unstructured":"Rendini T, Levis W. Quantiferon-Gold tuberculosis test cannot detect latent tuberculosis in patients with leprosy. Clin Infect Dis. 2015, 61:1439-40. 10.1093\/cid\/civ588","journal-title":"Clin Infect Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.0300-9475.2004.01358.x","article-title":"Immunological crossreactivity of the Mycobacterium leprae CFP-10 with its homologue in Mycobacterium tuberculosis","volume":"59","author":"Geluk A","year":"2004","unstructured":"Geluk A, van Meijgaarden KE, Franken KL, et al.. Immunological crossreactivity of the Mycobacterium leprae CFP-10 with its homologue in Mycobacterium tuberculosis. Scand J Immunol. 2004, 59:66-70. 10.1111\/j.0300-9475.2004.01358.x","journal-title":"Scand J Immunol"},{"key":"ref27","article-title":"Co-Infection with M. tuberculosis and M. leprae-case report and systematic review","volume":"2","author":"Rajagopala S","year":"2013","unstructured":"Rajagopala S, Devaraj U, D\u2019Souza G, Aithal VV. Co-Infection with M. tuberculosis and M. leprae-case report and systematic review. Mycobact Dis. 2013, 2:4.","journal-title":"Mycobact Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.14308","article-title":"Co-infection leprosy and tuberculosis: a systematic review","volume":"15","author":"Cavalcante Trindade L","year":"2021","unstructured":"Cavalcante Trindade L, Da Silveira Mendes M, Concei\u00e7\u00e3o Martins L, Carlos Evangelista de A Bonfim A, Fonseca FL. Co-infection leprosy and tuberculosis: a systematic review. J Infect Dev Ctries. 2021, 15:1569-77. 10.3855\/jidc.14308","journal-title":"J Infect Dev Ctries"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2105\/ajph.87.12.1923","article-title":"Leprosy and tuberculosis: the epidemiological consequences of cross-immunity","volume":"87","author":"Lietman T","year":"1997","unstructured":"Lietman T, Porco T, Blower S. Leprosy and tuberculosis: the epidemiological consequences of cross-immunity. Am J Public Health. 1997, 87:1923-7. 10.2105\/ajph.87.12.1923","journal-title":"Am J Public Health"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.5935\/0305-7518.19530009","article-title":"Tuberculosis and leprosy: mutually antagonistic diseases","volume":"24","author":"Chaussinnd R","year":"1953","unstructured":"Chaussinnd R. Tuberculosis and leprosy: mutually antagonistic diseases. Lepr Rev. 1953, 24:90-4. 10.5935\/0305-7518.19530009","journal-title":"Lepr Rev"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(06)70412-1","article-title":"The role of BCG in prevention of leprosy: a meta-analysis","volume":"6","author":"Setia MS","year":"2006","unstructured":"Setia MS, Steinmaus C, Ho CS, Rutherford GW. The role of BCG in prevention of leprosy: a meta-analysis. Lancet Infect Dis. 2006, 6:162-70. 10.1016\/S1473-3099(06)70412-1","journal-title":"Lancet Infect Dis"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)02166-6","article-title":"Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group","volume":"348","year":"1996","unstructured":"Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group. Lancet. 1996, 348.17-24. 10.1016\/S0140-6736(96)02166-6","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/141932-a-rare-case-of-hansens-disease-complicated-by-g6pd-deficiency","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:03:52Z","timestamp":1707509032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/141932-a-rare-case-of-hansens-disease-complicated-by-g6pd-deficiency"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.42816","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,1]]}}}